NASDAQ:ALIM
Alimera Sciences Stock News
$3.49
+0.180 (+5.44%)
At Close: Apr 26, 2024
New Strong Sell Stocks for March 13th
09:01am, Wednesday, 13'th Mar 2024
ASLE, ALIM and CADE have been added to the Zacks Rank #5 (Strong Sell) List on March 13, 2024.
Alimera Sciences (ALIM) Reports Q4 Loss, Tops Revenue Estimates
10:01am, Thursday, 07'th Mar 2024
Alimera Sciences (ALIM) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.02. This compares to loss of $0.54 per share a year ago.
Alimera Sciences (ALIM) Reports Q2 Loss, Lags Revenue Estimates
10:00am, Thursday, 10'th Aug 2023
Alimera Sciences (ALIM) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of $0.06. This compares to loss of $0.45 per share a year ago.
Alimera Sciences to Report Second Quarter 2023 Financial Results on August 10, 2023, and Provide Corporate Update
11:43am, Wednesday, 02'nd Aug 2023
ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners conce
Alimera Sciences (ALIM) Is Attractively Priced Despite Fast-paced Momentum
09:52am, Thursday, 08'th Jun 2023
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Alimera Sciences (ALIM) could be a great choice. It is one of the several stocks tha
Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year?
10:49am, Thursday, 01'st Jun 2023
Here is how Alimera Sciences (ALIM) and Haemonetics (HAE) have performed compared to their sector so far this year.
Alimera (ALIM) Completes Enrollment in Eye Disease Study
11:17am, Thursday, 25'th May 2023
Alimera (ALIM) announces completion of patient enrollment in its NEW DAY study to evaluate Iluvien 0.19 mg as a baseline therapy in diabetic macular edema. The stock surges 8% on Wednesday.
Alimera Sciences (ALIM) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:53am, Tuesday, 23'rd May 2023
Alimera Sciences (ALIM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stock
Alimera (ALIM) Up on Deal With Eyepoint for U.S. Rights to Yutiq
01:46pm, Friday, 19'th May 2023
Alimera Sciences ALIM announced acquiring additional U.S. commercialization rights for 0.18 mg dose strength of Yutiq from EyePoint Pharmaceuticals, Inc. Yutiq is indicated to treat chronic non-infe
How to Develop a Penny Stocks Trading Mentality
06:00am, Friday, 19'th May 2023
Can these tips help you become a better penny stocks trader? The post How to Develop a Penny Stocks Trading Mentality appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
10:52am, Thursday, 18'th May 2023
Alimera Sciences (NASDAQ: ALIM ) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (NASDAQ: EYPT ). That agreement has Alimera Sciences acquiring additional comm
Alimera Sciences (ALIM) Reports Q1 Loss, Tops Revenue Estimates
10:41am, Monday, 15'th May 2023
Alimera Sciences (ALIM) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.85 per share a year ago.
Alimera Sciences to Report First Quarter 2023 Financial Results on May 15, 2023, and Provide Corporate Update
08:00am, Monday, 08'th May 2023
ATLANTA, May 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concer
Alimera Sciences (ALIM) Reports Q4 Loss, Misses Revenue Estimates
10:45am, Friday, 31'st Mar 2023
Alimera Sciences (ALIM) delivered earnings and revenue surprises of -92.86% and 11.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Conference Call to be held Friday, March 31, at 9:00am Eastern Time Conference Call to be held Friday, March 31, at 9:00am Eastern Time
